COVID-19 Infection in Spinal Muscular Atrophy Associated with Multisystem Inflammatory Syndrome
The coronavirus disease-2019 (COVID-19) is usually less severe and less prevalent in the pediatric population. Children with preexisting conditions such as neuromuscular impairments and chronic lung disease are more susceptible to COVID-19 and may incur several complications with a poor outcome. We...
Saved in:
Main Authors: | Rafat Mosalli, Amirah Al Matrafi, Mohammed A. Ghazi, Gamal A. Aboumousatafa, Bosco Paes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2021/5862444 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Status of Treatment of Spinal and Bulbar Muscular Atrophy
by: Fumiaki Tanaka, et al.
Published: (2012-01-01) -
Unraveling the genetic mysteries of spinal muscular atrophy in Chinese families
by: Shanshan Gao, et al.
Published: (2025-01-01) -
Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy
by: Hooi Ling Teoh, et al.
Published: (2017-01-01) -
De Novo Heterozygous Mutation in FGFR2 Causing Type II Pfeiffer Syndrome
by: Rafat Mosalli, et al.
Published: (2022-01-01) -
Healthcare Utilization, Costs of Care, and Mortality Among Patients With Spinal Muscular Atrophy
by: Hiangkiat Tan, et al.
Published: (2019-12-01)